Occurrence of EDC/PPCPs in Influent and Effluent of a Wastewater Treatment Plant |
Lee, Min-Ju
(Department of Civil & Environmental Engineering, Chung-Ang University)
Ryu, Jae-Na (Department of Civil & Environmental Engineering, Chung-Ang University) Oh, Je-Ill (Department of Civil & Environmental Engineering, Chung-Ang University) Kim, Hyun-Bae (POSCO Engineering & Construction) |
1 | Lindqvist, N., Tuhkanen, T., Kronberg, L., “Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters,” Water Res., 39, 2219-2228(2005) DOI ScienceOn |
2 | Stasinakis, A. S., Gatidou, G., Mamais, D., Thomaidis, N. S., and Lekkas, T. D., “Occurrence and fate of endocrine disrupters in Greek sewage treatment plants,” Water Res., 42, 1796-1804(2008) DOI ScienceOn |
3 | Ashton, D., Hilton, M., and Thomas, K. V., “Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom,” Sci. Total Environ., 333, 167-184(2004) DOI ScienceOn |
4 | Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., and Buxton, H. T.“, Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U. S. Streams, 1999-2000: A National Reconnaissance,” Environ. Sci. Technol., 36, 1202-1211(2002) DOI ScienceOn |
5 | 김주형, 박찬구, 김민영, 안승구, “LC/MS 를 이용한 물 환경내의잔류의약품 분석,” 한국환경분석학회지, 11(2), 99-108(2008a) |
6 | Shane, A. S., Brett, J. V., Jrg, D., Eric, D., Erin, M. S., Gretchen, M. B., and Richard, C. P., State of Knowledge of Endocrine Disruptors and Pharmaceuticals in Drinking Water, Awwa Research Foundation, Denver, CO(2008) |
7 | Clara, M., Kreuzinger, N., Strenn, B., Gans, O., and Kroiss, H., “The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants,” Water Res., 39, 97-106 (2005) DOI ScienceOn |
8 | Gmez, M. J., Mart nez Bueno, M. J., Lacorte, S., Fern ndez-Alba, A. R., and Ag era, A., “Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast,” Chemosphere, 66, 993-1002(2007) DOI ScienceOn |
9 | Ternes, T. A., and Hirsch, R., “Occurrence and behavior of Xray contrast media in sewage facilities and the aquatic environment,” Environ. Sci. Technol., 34, 2741-2748(2000) DOI ScienceOn |
10 | Quintana, J. B., Weiss, S., and Reemtsma, T., “Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor,” Water Res., 39, 2654-2664(2005) DOI ScienceOn |
11 | Nakada, N., Tanishima, T., Shinohara, H., Kiri, K., and Takada, H., “Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment,” Water Res., 40,. 3297-3303(2006) DOI ScienceOn |
12 | Glassmeyer, S. T., Furlong, E. T., Kolpin, D. W., Cahill, J. D., Zaugg, S. D., Werner, S. L., Meyer, M. T., and Kryak, D. D., “Transport of Chemical and Microbial Compounds from Known Wastewater Discharges: Potential for Use as Indicators of Human Fecal Contamination,” Environ. Sci. Technol., 39, 5157-5169(2005) DOI ScienceOn |
13 | Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D., and Snyder, S. A., “Pharmaceuticals and Endocrine Disrupting Compounds in U.S. Drinking Water,” Environ. Sci. Technol., 43, 597-603(2009) DOI ScienceOn |
14 | KFDA ezdrug, available at http://ezdrug.kfda.go.kr/ |
15 | Andreozzi, R., Battilotti, M., Campanella, L., Lyberatos, G., Garric, J., and Paxeus, N. “Ecotoxicological assessments and removal technologies for pharmaceuticals in wastewaters,” Challenges in Environmental Risk Assessment and Modelling, 12-16(2002) |
16 | Carballa, M., Omil, F., Lema, J. M., Llompart, M., Garcia-Jares, C., Rodr guez, I., G mez, M., and Ternes, T., “Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant,” Water Res., 38, 2918-2926(2004) DOI ScienceOn |
17 | Kims online, available at http://www.kimsonline.co.kr/ |
18 | Ellis, J. B., "Pharmaceutical and personal care products (PPCPs) in urban receiving waters,” Environ. Pollu., 144, 184-189 (2006) DOI ScienceOn |
19 | Jjemba, P. K., “Excretion and ecotoxicity of pharmaceutical and personal care products in the environment,” Ecotoxicol. Environ. Saf., 63, 113-130(2006) DOI PUBMED ScienceOn |
20 | Ternes, T. A., Hirsch, R., Mueller, J., and Haberer, K., “Methods for the determination of neutral drugs as well as betablockers and 2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS,” Fresenius J. Anal. Chem., 362, 329-340(1998) DOI ScienceOn |
21 | Katzung, B. G., “Basic & clinical pharmacology,” McGraw-Hill Medical(2007) |
22 | Vanderford, B. J., and Snyder, S. A., “Analysis of Pharmaceuticals in Water by Isotope Dilution Liquid Chromatography/Tandem Mass Spectrometry,” Environ. Sci. Technol., 40, 7312-7320(2006) DOI ScienceOn |
23 | 김주형, 박찬구, 김민영, 안승구, “한강수계 상류지역의 동물용항생제 및 합성항균제 잔류실태 파악,” 한국환경분석학회지, 11(2), 109-118(2008b) |
24 | Tauxe-Wuersch, A., De Alencastro, L. F., Grandjean, D., and Tarradellas, J., “Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment,” Water Res., 39, 1761-1772(2005) DOI ScienceOn |
25 | Ternes, T. A., and Joss, A., “Human pharmaceuticals, hormones and fragrances: the challenge of micropollutants in urban water management,” IWA Publising (2006) |
26 | Kim, S. D., Cho, J., Kim, I. S., Vanderford, B. J., and Snyder, S. A., “Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters,” Water Res., 41, 1013-1021(2007) DOI ScienceOn |
27 | Trenholm, R. A., Vanderford, B. J., and Snyder, S. A., “Analytical Methods for Measuring Endocrine Disruptors and Pharmaceuticals,” World Environmental and Water Resources Congress, American Society of Civil Engineers(2007) |
28 | Skadsen, J. M., Rice, B. L., and Meyering, D. J., “The occurrence and fate of pharmaceuticals, personal care products and endocrine disrupting compounds in a municipal water use cycle: A case study in the city of Ann Arbor.” City of Ann Arbor: Water Utilities and Fleis & VandenBrink Engineering, Inc(2004) |
29 | 국립환경과학원, “환경 중 의약물질 분석방법 연구 및 노출실태조사(II),” (2007) |
30 | 한국제약협회, “2007년 의약품등 생산실적표”, (2007) |